Mass spectrometry has been rapidly maturing as the core technology at the heart of proteomics. The application of these powerful methods to the study of human diseases and their translation to the clinic, however, has been beset with unique challenges.
References
Petricoin, E., Wulfkuhle, J., Espina, V. & Liotta, L.A. J. Proteome Res. 3, 209–217 (2004).
Conrads, T.P., Hood, B.L., Petricoin, E.F., III, Liotta, L.A. & Veenstra, T.D. Expert Rev. Proteomics 2, 693–703 (2005).
Hanash, S. Nature 422, 226–232 (2003).
Massion, P.P. & Caprioli, R.M. J. Thorac. Oncol. 1, 1027–1039 (2006).
Marko-Varga, G. et al. J. Proteome Res. 6, 2925–2935 (2007).
Mayr, M. et al. Mol. Cell. Proteomics 5, 1853–1864 (2006).
Fu, Q. & Van Eyk, J.E. Expert Rev. Proteomics 3, 237–249 (2006).
Diamandis, E.P. J. Natl. Cancer Inst. 96, 353–356 (2004).
Karsan, A. et al. Clin. Chem. 51, 1525–1528 (2005).
Solassol, J. et al. Expert Rev. Proteomics 3, 311–320 (2006).
van der Merwe, D.E., Oikonomopoulou, K., Marshall, J. & Diamandis, E.P. Adv. Cancer Res. 96, 23–50 (2007).
deVera, I.E., Katz, J.E. & Agus, D.B. Clin. Adv. Hematol. Oncol. 4, 541–549 (2006).
Veenstra, T.D. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 847, 3–11 (2007).
Mischak, H. et al. Proteomics Clin. Appl. 1, 148–156 (2007).
Hernandez, P., Muller, M. & Appel, R.D. Mass Spectrom. Rev. 25, 235–254 (2006).
Barker, P.E. et al. Clin. Chem. 52, 1669–1674 (2006).
Prakash, A. et al. Mol. Cell. Proteomics, published online 27 July 2007 (doi:10.1074/mcp.M600470-MCP200).
Taylor, C.F. et al. OMICS 10, 145–151 (2006).
Zhang, H. et al. Mol. Cell. Proteomics 6, 64–71 (2007).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Beretta, L. Proteomics from the clinical perspective: many hopes and much debate. Nat Methods 4, 785–786 (2007). https://doi.org/10.1038/nmeth1007-785
Issue Date:
DOI: https://doi.org/10.1038/nmeth1007-785
- Springer Nature America, Inc.